CUSIP: 576810105
Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
26,293,621
-
Share change
-
-6,045,328
-
Total reported value
-
$16,582,017
-
Price per share
-
$0.63
-
Number of holders
-
35
-
Value change
-
-$5,754,546
-
Number of buys
-
14
-
Number of sells
-
20
Quarterly Holders Quick Answers
What is CUSIP 576810105?
CUSIP 576810105 identifies MTNB - MATINAS BIOPHARMA HLDGS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2019
-
Previous quarter:
Q2 2019
Recent filing periods for CUSIP 576810105:
Institutional Holders of MATINAS BIOPHARMA HLDGS INC - COM (MTNB) as of Q3 2019
As of 30 Sep 2019,
MATINAS BIOPHARMA HLDGS INC - COM (MTNB) was held by
35 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
26,293,621 shares.
The largest 10 holders included
BOXER CAPITAL, LLC, VANGUARD GROUP INC, BAKER BROS. ADVISORS LP, VICTORY CAPITAL MANAGEMENT INC, Granite Point Capital Management, L.P., GEODE CAPITAL MANAGEMENT, LLC, ROYAL BANK OF CANADA, Raymond James Financial Services Advisors, Inc., BlackRock Inc., and Telemetry Investments, L.L.C..
This page lists
35
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.